Membrane Metalloendopeptidase (MME) is the prototype of the membrane bound zinc-dependent endopeptidase family, and it is also overexpressed in numerous malignancies, including colorectal carcinoma, pancreatic endocrine tumors, and metastatic melanomas. Here, MME is linked to pancreatic neuroendocrine tumor.